Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Disitamab Vedotin for Adults with Previously Treated HER2-Positive Solid Tumors, Including Lung, Head and Neck, Ovarian, and Endometrial Cancers

    Not yet recruiting

    1 1
    Investigated drugs:
    France Germany Italy Spain
  • A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

    Not recruiting

    1 1 1
    Investigated drugs:
    Portugal
  • Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

    Not recruiting

    1 1
    Investigated drugs:
    Belgium Denmark France Italy Spain
  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1
    Investigated drugs:
    Spain
  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    1 1 1
    Belgium Estonia Germany Greece Hungary Lithuania +2
  • Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia Denmark Finland France +9
  • Study of Giredestrant for Patients with Grade 1 Endometrial Cancer

    Not recruiting

    1 1
    Investigated drugs:
    Italy Poland
  • A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

    Not recruiting

    1 1
    Germany The Netherlands Spain